Skip to main content
Premium Trial:

Request an Annual Quote

Alex van Belkum, Carlo Croce, Herbert Fritsche, Joe Gray, Patrick Murray, Franklyn Prendergast, David Relman, Michael Sarosdy, Matt Ruby, Dino DiCamillo, Ian Taylor

Cepheid has appointed eight members to its scientific advisory board. The new members include Alex van Belkum, professor of molecular microbiology at the department of medical microbiology and infectious diseases, Erasmus Medical Center, in Rotterdam, The Netherlands; Carlo Croce, chairman of the department of molecular virology, immunology and medical genetics at Ohio State University; Herbert Fritsche, chief of clinical chemistry at the University of Texas MD Anderson Cancer Center; Joe Gray, director of the life sciences division of Lawrence Berkeley National Laboratory; Patrick Murray, chief of the microbiology service, department of laboratory medicine, National Institutes of Health Clinical Center; Franklyn Prendergast, director of the Mayo Clinic Center for Individualized Medicine; David Relman, chief of infectious diseases at Palo Alto Veterans’ Administration Hospital; and Michael Sarosdy, a urologic surgeon at the Cancer Therapy and Research Center in San Antonio, Texas.
 

 
Matt Ruby has joined Advanced Micro-Fabrication Equipment as vice president and legal and general counsel, the China-based semiconductor processing company said last week. He joins AMEC from Sanmina-SCI, where he served as corporate counsel. Prior to that, he spent seven years at Applied Biosystems, where he served as senior counsel and manager of the legal department international group, leading the company's overseas legal affairs. Ruby received his JD from Santa Clara University School of Law and a certificate in international and comparative law from MagdalenCollegeat the University of Oxford.
 

 
Dino DiCamillo has joined ART Advanced Research Technologies as vice president for global sales and marketing of preclinical imaging, the Montreal-based medical device company said last week. Prior to joining ART, DiCamillo was president of the proteomic technology division of Alfa Wassermann. Previously, he was a senior field manager at Applied Biosystems. DiCamillo holds an EMBA from TempleUniversity and a BS in biology from Lake Superior State University.
 
ART also appointed Mark Sutherland to its business advisory council. Sutherland is chief business officer at FlashPoint Technology and has held senior positions at GE Healthcare, Amersham Biosciences, Molecular Dynamics, and Applied Biosystems.
 

 
Cellexus Biosystems this week announced the appointment of Ian Taylor as commercial director.
 

Taylor previously held senior management positions at Genetix, PerkinElmer Life & Analytical Sciences, Genomic Solutions, PerSeptive Biosystems, and EG&G Wallac.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.